pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4732 |
Genomic Coordinates | chr17: 28861655 - 28861730 |
Description | Homo sapiens miR-4732 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4732-5p | |||||||||||||||||||||||||||||||||
Sequence | 9| UGUAGAGCAGGGAGCAGGAAGCU |31 | |||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ZNF138 | ||||||||||||||||||||
Synonyms | pHZ-32 | ||||||||||||||||||||
Description | zinc finger protein 138 | ||||||||||||||||||||
Transcript | NM_001160183 | ||||||||||||||||||||
Other Transcripts | NM_006524 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ZNF138 | |||||||||||||||||||||
3'UTR of ZNF138 (miRNA target sites are highlighted) |
>ZNF138|NM_001160183|3'UTR 1 AGCAGAACATAAAAGATTCTTTCCAAAAAGTGACACTGAGCAGATATGGAAAATATGGACATAAGAATTTACAGTTAAGA 81 AAAGGCTGTAAAAGTGTGGATGAGTGTAAGGGACACCAAGGAGGTTATAATGGACTTAACCAATGTTTGAAAATTACCAC 161 AAGCAAAATATTTCAATGTAATAAATATGTAAAAGTCATGCATAAATTTTCAAATTCAAATAGACACAAGATAAGACATA 241 CTGAAAATAAACATTTCAGATGTAAAGAATGTGACAAATCACTTTGCATGCTTTCACGCCTAACTCAACATAAAAAAATT 321 CATACTAGAGAGAATTTCTACAAATGTGAAGAGTGTGGAAAAACCTTTAACTGGTCCACAAACCTTTCTAAACCTAAGAA 401 AATTCATACTGGAGAAAAACCCTACAAATGTGAAGTATGTGGAAAAGCCTTTCACCAATCCTCAATCCTTACTAAACATA 481 AGATAATTCGTACTGGAGAAAAACCCTATAAATGTGCACACTGTGGCAAAGCCTTTAAACAGTCCTCACACCTTACTAGA 561 CATAAGATAATTCATACTGAAGAGAAACCCTACAAATGTGAACAATGTGGCAAGGTCTTTAAGCAGTCCCCAACCCTTAC 641 TAAACATCAGATAATTTATACTGGAGAGGAACCATACAAATGTGAGGAATGTGGCAAAGCTTTTAACCTATCTTAACAAC 721 TTACTGAACATAAGAAAATTTACACTAGAGAGAAAGCCTACAAATGTGAAGAATGTGGCAAAGCCTTTAACCAGTTTTCA 801 ACCCTTATTACACATAAGATAATTCATAGCGGAGAGAAACCCCACAAATGTGAAGAATGTGGCAGAGCTTTTAACCAGTC 881 CGCAAAGCTCACTGAACATAAGTTAATTCATACTGGAGAAAAACCCTACAAATGTAAAGAATGTGGAAAAGCTTTTCACC 961 GATACTCAATCCTTAGTACACATAAGAAAATTCATACTGGGGAGAAACCCCACAAATGTGGAGAATGCGGAAAAGCCTTT 1041 AACTGGTCCTCAACTCTTATTACACATAAGATAATTCACAGTGGAGAAAAACCCTACAAATGTGAAGAATGTGGCAAAGC 1121 TTTTAACCAGTCCTCACACCTTATGAGACATAAGAAAATTCATAGTAAAGAGAAACCCTACAAATGTGAACAGTGTGGCA 1201 AGGTCTTTAAGAAGTCCTCAACTCTTACTGCACATAAGATCATTCATACTGGAGAGAAACCTTACAAATGTGAGGAATGT 1281 GGCAAAGGTTTTAGCCAACTCTCAAACCTTACTAAACACAAGAAGATTCATACTAGAGAGAAACCCTACAAATGTGAAGA 1361 ATGTGGCATATCTTTTAACCAGTTCTCACAACTTGCTATACATAAGATGATTCACACTTGAATGAAACCCTACAAATGTG 1441 AACGATGTGGCAGTTGTTTTAACTAGTTCTCGAACTTTACTATGCATAAGAAAATTCAAACTGGAGAGAAACTCTACAAA 1521 TGTGAAGAATGTGGCAAAGCTTTTAACCAAGTCTCAACACTTACTATACATAAGATAATTTATACTGGAGCAAAACCTTG 1601 GAAATTCAAAGAATGTGGTAAAACTTACAATCCTCAAAACTTCTTACACCTAAAATTCATGCAGGAGAGAAACACCACAA 1681 ATGTGAAAAATTTGGTAAATTCTTTAACAAGTCTTCAACCCTTTCTGCACATAATATAATTCATACTGGAGAGAAACCCC 1761 ACAAATATGAAGAATGTGGTAATGCTTTTAACCAATTCTCAAATCTTACTAAACAAAATTAATACTGAAAATGTTACAAA 1841 CCAGAAAAATGTGAAAATGATTTTAACAAAACCTTCAAATTTTTCTAAACATAAAGGAAATCATACTGGTAAGAAATTAT 1921 AAAAATGTGAAGAATGTGACAAAGCCTTTAAATGGTTGTCACACTTGATTGTAGGTAAGATAATTCATACTGGCAGAAAC 2001 TCCCAGAAGTGTGAAGAATATGGCAAAACTTTAATTCCTATACCTTATTGCACAGGAAAGCATTTATACTTCAGAAAATG 2081 TTGTACTGATATAAAGAATGTAGAAAAGCCATTAATATGTGCTTACATCTTATTCAACATTAGAGAGTTAGTACTTAATA 2161 AAAGCATTATAAATGCAATTACTGTCAAAACTCAG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 7697.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_006524 | 3UTR | UGGAGAGAAACUCUACAAAUGUGAAGAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_006524 | 3UTR | GAGAAACUCUACAAAUGUGAAGAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_006524 | 3UTR | ACUGGAGAGAAACUCUACAAAUGUGAAGAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_006524 | 3UTR | GAGAGAAACUCUACAAAUGUGAAGAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_006524 | 3UTR | CUGGAGAGAAACUCUACAAAUGUGAAGAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_006524 | 3UTR | UUCAAACUGGAGAGAAACUCUACAAAUGUGAAGAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000440598.1 | 3UTR | AAACUCUACAAAUGUGAAGAAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
65 hsa-miR-4732-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT076214 | ALKBH5 | alkB homolog 5, RNA demethylase | 2 | 2 | ||||||||
MIRT443015 | C21orf91 | chromosome 21 open reading frame 91 | 2 | 2 | ||||||||
MIRT450317 | ZNF562 | zinc finger protein 562 | 2 | 2 | ||||||||
MIRT450522 | ZNF236 | zinc finger protein 236 | 2 | 2 | ||||||||
MIRT453952 | ENTHD1 | ENTH domain containing 1 | 2 | 2 | ||||||||
MIRT463438 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | 2 | 2 | ||||||||
MIRT463971 | WHSC1 | nuclear receptor binding SET domain protein 2 | 2 | 4 | ||||||||
MIRT465545 | TOB2 | transducer of ERBB2, 2 | 2 | 2 | ||||||||
MIRT473817 | MAP2K7 | mitogen-activated protein kinase kinase 7 | 2 | 2 | ||||||||
MIRT476716 | FRK | fyn related Src family tyrosine kinase | 2 | 4 | ||||||||
MIRT477373 | ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | 2 | 2 | ||||||||
MIRT477756 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 2 | ||||||||
MIRT479642 | CD4 | CD4 molecule | 2 | 2 | ||||||||
MIRT483891 | IL20RB | interleukin 20 receptor subunit beta | 2 | 6 | ||||||||
MIRT485654 | DAZAP2 | DAZ associated protein 2 | 2 | 10 | ||||||||
MIRT493568 | HSP90AA1 | heat shock protein 90 alpha family class A member 1 | 2 | 8 | ||||||||
MIRT499708 | NFATC2IP | nuclear factor of activated T-cells 2 interacting protein | 2 | 10 | ||||||||
MIRT499933 | MFSD8 | major facilitator superfamily domain containing 8 | 2 | 2 | ||||||||
MIRT509169 | EFHC1 | EF-hand domain containing 1 | 2 | 4 | ||||||||
MIRT510594 | TUBB2A | tubulin beta 2A class IIa | 2 | 2 | ||||||||
MIRT510832 | RTN4RL1 | reticulon 4 receptor like 1 | 2 | 6 | ||||||||
MIRT512419 | LAYN | layilin | 2 | 4 | ||||||||
MIRT516109 | OARD1 | O-acyl-ADP-ribose deacylase 1 | 2 | 8 | ||||||||
MIRT517204 | OTUD6A | OTU deubiquitinase 6A | 2 | 2 | ||||||||
MIRT519106 | ALG1 | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase | 2 | 2 | ||||||||
MIRT519283 | SPCS1 | signal peptidase complex subunit 1 | 2 | 2 | ||||||||
MIRT519823 | ZKSCAN4 | zinc finger with KRAB and SCAN domains 4 | 2 | 2 | ||||||||
MIRT521976 | PFN2 | profilin 2 | 2 | 4 | ||||||||
MIRT526729 | ZNF138 | zinc finger protein 138 | 2 | 2 | ||||||||
MIRT528765 | CD1D | CD1d molecule | 2 | 2 | ||||||||
MIRT531567 | ILDR1 | immunoglobulin like domain containing receptor 1 | 2 | 2 | ||||||||
MIRT532173 | SEC14L5 | SEC14 like lipid binding 5 | 2 | 4 | ||||||||
MIRT534865 | QSER1 | glutamine and serine rich 1 | 2 | 2 | ||||||||
MIRT539948 | SLC30A5 | solute carrier family 30 member 5 | 2 | 2 | ||||||||
MIRT543594 | KIAA1549 | KIAA1549 | 2 | 2 | ||||||||
MIRT543964 | RNF20 | ring finger protein 20 | 2 | 2 | ||||||||
MIRT544747 | C8orf33 | chromosome 8 open reading frame 33 | 2 | 2 | ||||||||
MIRT544871 | EHD3 | EH domain containing 3 | 2 | 2 | ||||||||
MIRT550459 | OSCAR | osteoclast associated, immunoglobulin-like receptor | 2 | 2 | ||||||||
MIRT551950 | RNF157 | ring finger protein 157 | 2 | 2 | ||||||||
MIRT552504 | ZIK1 | zinc finger protein interacting with K protein 1 | 2 | 4 | ||||||||
MIRT554074 | SNX4 | sorting nexin 4 | 2 | 4 | ||||||||
MIRT555952 | NUBP1 | nucleotide binding protein 1 | 2 | 2 | ||||||||
MIRT561097 | VAMP8 | vesicle associated membrane protein 8 | 2 | 2 | ||||||||
MIRT561827 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 2 | ||||||||
MIRT563962 | ZNF431 | zinc finger protein 431 | 2 | 2 | ||||||||
MIRT566851 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT608133 | TGFBR2 | transforming growth factor beta receptor 2 | 2 | 2 | ||||||||
MIRT615716 | ZNF383 | zinc finger protein 383 | 2 | 2 | ||||||||
MIRT615959 | ERBB3 | erb-b2 receptor tyrosine kinase 3 | 2 | 4 | ||||||||
MIRT620031 | ST6GALNAC3 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | 2 | 2 | ||||||||
MIRT621102 | IL36B | interleukin 36, beta | 2 | 2 | ||||||||
MIRT627383 | TNNC1 | troponin C1, slow skeletal and cardiac type | 2 | 2 | ||||||||
MIRT628263 | DOK6 | docking protein 6 | 2 | 2 | ||||||||
MIRT635011 | PDHB | pyruvate dehydrogenase E1 beta subunit | 2 | 2 | ||||||||
MIRT636129 | YIPF4 | Yip1 domain family member 4 | 2 | 2 | ||||||||
MIRT646812 | COX19 | COX19, cytochrome c oxidase assembly factor | 2 | 2 | ||||||||
MIRT652099 | TRUB2 | TruB pseudouridine synthase family member 2 | 2 | 2 | ||||||||
MIRT662038 | KSR2 | kinase suppressor of ras 2 | 2 | 2 | ||||||||
MIRT691530 | ZNF208 | zinc finger protein 208 | 2 | 2 | ||||||||
MIRT698030 | TRPV2 | transient receptor potential cation channel subfamily V member 2 | 2 | 2 | ||||||||
MIRT706642 | NCBP2 | nuclear cap binding protein subunit 2 | 2 | 2 | ||||||||
MIRT707919 | PRIMA1 | proline rich membrane anchor 1 | 2 | 2 | ||||||||
MIRT714664 | CHRNE | cholinergic receptor nicotinic epsilon subunit | 2 | 2 | ||||||||
MIRT721201 | ZNF724P | zinc finger protein 724 | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|